Other acquired resistance mechanisms, including small cell lung cancer or squamous cell transformation, mutation in PIK3CA, BRAF, HER2, KRAS, NRAS, MEK1, AKT2, LKB1 and JAK2, were not detected. Here, ERBB2 is linked to small cell lung carcinoma.